Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 24.63% institutional investors, 41.57% insiders, and 33.81% retail investors. Millennium management is the largest institutional shareholder, holding 5.42% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals24.63%41.57%33.81%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management809.90K5.42%$3.43M
Ikarian capital595.93K3.99%$2.00M
Renaissance507.16K3.61%$1.20M
Vanguard group374.25K2.66%$886.98K
Dimensional fund advisors lp272.97K1.94%$646.94K
J. goldman & co lp220.71K1.48%$739.37K
Bridgeway capital management184.16K1.31%$436.45K
Boothbay fund management180.23K1.21%$603.77K
Blackrock110.56K0.78%$169.16K
Bank of new york mellon75.27K0.54%$178.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital595.93K0.38%$2.00M
J. goldman & co lp220.71K0.02%$739.37K
Boothbay fund management180.23K0.01%$603.77K
Bridgeway capital management184.16K0.01%$436.45K
Renaissance507.16K0.00%$1.20M
Millennium management809.90K0.00%$3.43M
Xtx topco10.28K0.00%$34.44K
Acadian asset management44.29K0.00%$148.00K
Wiley bros.-aintree capital11.00K0.00%$36.85K
Cresset asset management19.48K0.00%$65.24K

Top Buyers

HolderShares% AssetsChange
Millennium management809.90K0.00%809.90K
Blackrock funding, inc. /de51.17K-18.51K
Two sigma investments, lp37.65K0.00%18.27K
Xtx topco10.28K0.00%10.28K
Newedge advisors1.43K-1.43K

Top Sellers

HolderShares% AssetsChange
Berkshire asset management llc/pa---153.81K
Adage capital partners gp---150.00K
Ikarian capital595.93K0.38%-144.07K
Bridgeway capital management184.16K0.01%-102.50K
Eam investors---71.78K

New Positions

HolderShares% AssetsChangeValue
Millennium management809.90K0.00%809.90K$3.43M
Xtx topco10.28K0.00%10.28K$34.44K
Newedge advisors1.43K-1.43K$4.78K
Farther finance advisors345.00-345.00$1.08K

Sold Out

HolderChange
Jpmorgan chase-19.00
Advisor group-100.00
Wells fargo & company/mn-250.00
Innealta capital-948.00
Centiva capital, lp-1.60K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202532-17.95%3,682,268-13.97%243.00%15-21.05%1011.11%
Mar 31, 20253-85.71%1,549,897-15.86%106.04%3-25.00%--100.00%
Dec 31, 202421-8.70%1,842,038-9.87%136.20%4-55.56%10150.00%
Sep 30, 202423-4.17%2,043,812-1.62%146.70%950.00%4-20.00%
Jun 30, 202424-2,077,457-3.95%146.44%620.00%5-44.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv274.81K1.84%-6.01K
Bridgeway Ultra-Small Company137.27K0.92%4.20K
Vanguard Institutional Extnd Mkt Idx Tr86.94K0.58%-39.62K
IMC US Ultra Micro Cap79.25K0.53%-
DFA US Targeted Value I65.60K0.44%2.30K
Bridgeway Ultra-Small Company Market49.89K0.33%-
DFA US Micro Cap I47.77K0.32%-
Fidelity Extended Market Index44.18K0.30%1.02K
Pleiades Small Cap Equity A39.62K0.28%39.62K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2025Young Caroline-Buy$20.64
Aug 26, 2025Young Caroline-Buy$20.34
Aug 29, 2025Young Caroline-Buy$20.70
Aug 28, 2025Young Caroline-Buy$20.82
Aug 25, 2025Young Caroline-Buy$19.92

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 24.63%, followed by 41.57% insiders and 33.80% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Millennium management (809.9K shares, 5.42%), Ikarian capital (595.93K shares, 3.99%), and Renaissance (507.16K shares, 3.61%). Together, they hold 13.01% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 595.93K Cumberland Pharmaceuticals shares, valued at 2M$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools